Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,424 | 55,912 | 55,135 | 19,053 | 335,844 |
| Marketable Securities | 75,326 | 164,195 | 136,813 | 305,937 | N/A |
| Receivables | 14,409 | 32,203 | 18,222 | 16,376 | 12,688 |
| TOTAL | $168,145 | $275,321 | $223,535 | $349,896 | $355,517 |
| Non-Current Assets | |||||
| PPE Net | 8,138 | 4,767 | 4,781 | 7,596 | 5,476 |
| Intangibles | 3,560 | 4,149 | 3,076 | 0 | 0 |
| Other Non-Current Assets | 39,064 | 38,172 | 49,545 | 41,789 | 5,049 |
| TOTAL | $50,762 | $47,088 | $57,402 | $49,385 | $10,525 |
| Total Assets | $218,907 | $322,409 | $280,937 | $399,281 | $366,042 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,318 | 10,008 | 8,823 | 11,984 | 18,125 |
| Accrued Expenses | 34,437 | 24,318 | 28,943 | 37,980 | 29,780 |
| TOTAL | $60,567 | $42,793 | $51,561 | $55,856 | $47,905 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,991 | 32,086 | 20,204 | 24,699 | N/A |
| Deferred Revenues | 959 | 346 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 26,770 | 25,061 | 30,738 | 19,533 | 6,799 |
| TOTAL | $60,076 | $69,666 | $50,942 | $44,232 | $6,799 |
| Total Liabilities | $120,643 | $112,459 | $102,503 | $100,088 | $54,704 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 183,985 | 12,583 | 12,370 | N/A | N/A |
| Common Shares | 16,419 | 16,253 | 12,507 | 12,331 | 10,924 |
| Retained earnings | -900,884 | -750,224 | -605,640 | -453,661 | -290,239 |
| Other shareholders' equity | 26,018 | 3,246 | 373 | 2,042 | 3,163 |
| TOTAL | $98,264 | $209,950 | $178,434 | $299,193 | $311,338 |
| Total Liabilities And Equity | $218,907 | $322,409 | $280,937 | $399,281 | $366,042 |